STM publisher Elsevier has announced James Dunstan, Regional Manager Pharmaceutical Biotech Corporate Sales, presented at the recently concluded 2nd Annual Risk Management and Pharmacovigilance Summit held from September 15 - 17. Elsevier was also a silver sponsor of the Summit.
James presented to Summit attendees on how to optimise literature management throughout the entire pharmacovigilance workflow. James discussed industry trends and key developments in pharmacovigilance, as well as outlining key challenges that Elsevier has helped customers face. Through the use of a case study, James also evaluated the suitability of qualitative and quantitative methods used to assess the benefit-risk profile of marketed products.
In addition to attending the Summit, Elsevier will also be holding four 'pharmacovigilance days' across Europe in the coming months, as it continues to help companies both overcome the obstacles that huge amounts of scientific literature pose, and maintain compliance.
Elsevier offers several solutions and services for improved pharmacovigilance and risk monitoring, including Embase, the world's most comprehensive biomedical literature database for institutions and individuals; PharmaPendium, a fully searchable database of drug approval documents and extracted data to inform critical drug development decisions; and QUOSA, an end-to-end scientific literature management tool for life science professionals, used by companies such as Sanofi. Elsevier is also currently developing and expanding its solutions and services offered in this space.
Brought to you by Scope e-Knowledge Center, a world-leading provider of abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
